Xcout IntelLifesenz Cancer competitors & alternatives
The 12 closest competitors and alternatives to Lifesenz Cancer among biotechnology companies — ranked by similarity to what Lifesenz Cancer actually does, not by market-cap band.
Subscribe to see Lifesenz Cancer’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Lifesenz Cancer
Lifesenz Cancer is a biomedical organization that develops 3D cell culture systems and patient-derived ex vivo models to predict individual chemotherapy responses and guide precision cancer therapy. The company also provides biopharmaceutical R&D training, workshops, and educational programs for students, researchers, and job seekers to bridge the gap between academia and industry.
Lifesenz Cancer at a glance
Lifesenz Cancer is a biotechnology company headquartered in India. Xcout tracks 5 named people at Lifesenz Cancer, including Dr. Arindam Banerjee (CEO and Director).
Lifesenz Cancer leadership
- Dr. Arindam BanerjeeCEO and Director
- Prof Peter E LobieProfessor & Co-Director
- Dr. Aditya MankeFounder, Senior Onco Surgeon
- Mr. Hanskumar ShahDirector
- Mr. Kaushik ShahDirector
Recent Lifesenz Cancer news
Top 12 Lifesenz Cancer competitors
Ranked by semantic similarity — how close each company is to Lifesenz Cancer by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Origin Bio operates a tissue-first data and model platform that maps cancer biology using patient tumor samples. The company generates spatial, molecular, and functional maps from real tumor tissue to support target discovery, drug response prediction, and multimodal AI modeling for researchers and life sciences partners.
Biotech, Diagnostics
Novigenix is an immuno-transcriptomics and TechBio company that provides precision oncology solutions for biopharmaceutical companies and researchers. It offers LITOseek, an AI-powered liquid biopsy platform that analyzes gene activity in immune cells to support biomarker discovery, therapy development, and patient response monitoring.
Similar biotechnology company
WittGen Inc. provides a virtual cell-to-patient profiling technology powered by single-cell generative AI for clinical leaders and biopharmaceutical researchers. The company's platform transforms archived bulk RNA samples and pathological image data into regulator-ready patient stratification insights and cellular-level biomarkers to de-risk clinical trials and accelerate oncology drug development.
Biotech
Indivumed GmbH is a precision oncology company that provides tumor and normal tissue samples, multi-omics and clinical data databases, biomathematical and AI tools, and patient-derived cellular models. The company serves researchers and pharmaceutical partners by conducting cancer target discovery, target validation, and therapeutic drug development.
Biotech
Parallel Bio provides a human-first drug discovery and precision medicine platform that maps human biology using patient samples and computational tools. The company serves pharmaceutical and biotechnology organizations by conducting faster, animal-free preclinical testing and generating proprietary human biological data.
Biotech
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Similar biotechnology company
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Similar biotechnology company
Shift Bioscience is a biotechnology research company based in Cambridge, United Kingdom, that employs generative AI virtual cell models to understand gene activation and cellular reprogramming.
Biotech
Established in 2003 and headquartered in Yokohama, Japan, ReproCELL Incorporated operates as a prominent firm specializing in stem cell research. The company furnishes an extensive portfolio of products crucial for various stem cell applications, including a diverse array of specialized reagents for RNA reprogramming, cell growth (such as small molecules, growth factors, and cytokines), cell characterization (like antibodies and staining kits), cell culture (including pluripotent stem cell media and cell substrates), and cell handling (such as cryopreservation media, dissociation solutions, and transfection reagents). Furthermore, ReproCELL provides differentiated induced pluripotent stem cells (iPSCs), related components like feeder cells and induced neurons, 3D cell culture systems, and general laboratory consumables. Complementing its product lines, the company offers a comprehensive suite of services, spanning preclinical genomics, dedicated stem cell research, drug development support (encompassing efficacy, safety, and ADME analyses), access to human tissue samples, therapeutic pipeline development, and a range of clinical services, including laboratory diagnostics and the creation of GMP iPSC master cell banks.
Biotech
VitroScan provides ex vivo micro-tumor testing platforms and predictive assays designed to forecast patient responses to cancer treatments. The company serves clinicians and biopharmaceutical developers by enabling personalized therapy selection, improving clinical trial stratification, and de-risking oncology drug development.
Similar biotechnology company
Pear Bio develops personalized cancer testing and drug discovery services for patients with hard-to-treat cancers. The company utilizes patient tumor biopsies to create 3D immune-microtumors in order to predict individual treatment responses and identify novel therapeutic targets.
Biotech
InSphero provides 3D in vitro cell culture models, microplates, organ-on-a-chip platforms, and related services for drug discovery and safety testing. The company serves pharmaceutical, biotechnology, and research organizations seeking non-animal testing alternatives to evaluate drug efficacy, liver safety, oncology, and other complex diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Lifesenz Cancer and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Lifesenz Cancerand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →